# LENZ Therapeutics, Inc.: Form S-1, filed Mar 29, 2024

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: S-1
- Filed: 2024-03-29
- Accepted by EDGAR: Mar 29, 2024, 16:46 ET
- Period: not reported
- Accession: 0001628280-24-013816
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000162828024013816/lenz-20240329.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000162828024013816/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000162828024013816/lenz-20240329.htm

Filed Mar 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-013816. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.